Replay available

Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call

Roivant Sciences Ltd. (NASDAQ: ROIV) Q4 2025 earnings conference call, held 2026-05-20. Replay captured from the company's public earnings webcast.

Wed, May 20, 2026 at 8:00 AMendedReplay
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Stephanie Lee

Investor Relations

Yaron Werber

Analyst, TD Cowen

Yasmeen Rahimi

Analyst, Piper Sandler

Dennis Sting

Analyst, Jefferies

Prakhar Agrawal

Analyst, Cantor Fitzgerald

Douglas O.

Analyst, DHC Wainwright

Drew Brumkin

Chief Executive Officer

Matt Glein

Chief Executive Officer

Derek Archilla

Analyst, Wells Fargo

Thomas Smith

Analyst, Laring Partners

Alex Thompson

Analyst, Stifel

Andy Chin

Analyst, Wolfe Research

David Reisinger

Analyst, Lyric Partners

Brian Chang

Analyst, J.P. Morgan

William Pickering

Analyst, Bernstein

Dina Ramadane

Analyst, Bank of America Securities

Corinne Johnson

Analyst, Goldman Sachs

Iris Gow

Analyst, Guggenheim

Sam Slutsky

Analyst, LifeSci Capital

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. Welcome to the Roy Van Forth Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. And to ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. We ask that you please limit to one question. And to withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would like now to turn the conference over to Stephanie Lee. Please go ahead. Good morning, and thanks for joining today's call to review business updates from Roy Vint's fourth quarter and fiscal year ended March 31, 2026. I'm Stephanie Lee with Roy Vint. Presenting today, we have Matt Glein, CEO of Oregon, and Drew Brumkin, CEO of Palmogans. For those dialing in via conference call, you can find the slides being presented today, as well as the press release announcing these updates on our IR website at www.investor.rogan.com. We'll also be providing the current slide numbers as we present to help you follow along. I'd like to remind you that we'll be making certain forward-looking statements during today's presentation. We strongly encourage you to review the information that we have filed with the SEC for more information regarding these forward-looking statements and related risks and uncertainties. And with that, I'll turn it over to Matt. Thanks, Stephanie. Thank you, everyone, for dialing in this morning. I'm glad to be talking. We have an unexpectedly busy agenda with a bunch of topics. I'm looking forward to going through all of it, including, obviously, what we announced this morning, which is ...

More from Roivant Sciences Ltd.